Patients were initially randomised to induction arms AVP ( adriamycin , etoposide and cisplatin given every four weeks for four cycles ) , EVA ( cyclophosphamide , etoposide and adriamycin given every four weeks for four cycles ) or MOC/AVP ( methotrexate , vincristine , cyclophosphamide alternating with adriamycin , etoposide and cisplatin given for two cycles ) .
